维普期刊资源整合服务平台（V6.5）

142篇 您的检索式：作者名="Rustin GJ"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	A review of the role of established tumor markers显示文摘	Beastall GH Cook B Rustin GJ	1991	Ann Clin Biochem1991，28，12：	1
2	The cost of surveillance following treatment of ovarian cancer显示文摘	Rustin GJ	2013	Gynecol Oncol2013，131，3：	1
3	Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer 显示文摘	Rustin GJ Bast RCJr KeUoff GJ	2004	Clin Cancer Res2004，10，11：	1
4	Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer显示文摘	Rustin GJ Bast RC Jr Kelloff CJ		0，，：	1
5	Combination but not single agent nethotrexate chemotherphy for gestaional trophoblastic turmors increase the incidence of second tumors显示文摘	Rustin GJ Newlands ES Lutz JM	1996	J Clin Oncol1996，14，10：	1
6	Comparison of standard and CA-125response criteria in patients with epithelial ovarian cancer treated with platinum or paclitaxel显示文摘	Bridgewater JA Nelstrop AE Rustin GJ	1999	J Clin Oncol1999，17，：	1
7	Role of tumour markers in monitoring epithelial ovarian cancer显示文摘	MEYER T RUSTIN GJ	2000	Br J Cancer2000，82，9：	1
8	Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer显示文摘	Rustin GJ Bast RC Jr Kelloff GJ	2004	Clin Cancer Res2004，10，11：	1
9	Defining progression of ovarian carcinoma during follow-up according to CA 125:a North Thames Ovary Group Study显示文摘	Rustin GJ Nelstrop AE Tuxen MK	1996	Ann Oncol1996，7，4：	1
10	Defining response of ovarian car-cinoma to initial chemotherapy according to serum CA125显示文摘	Rustin GJ Nelstrop AE McClean P	1996	J Clin Oncol1996，14，：	1
11	Defining progression of ovarian carcinoma during follow-up according to CA125:a North Thames Ovary Group Study显示文摘	Rustin GJ Nelstrop AE Tuxen MK	1996	Ann Oncol1996，7，：	1
12	CA 125 response:can it replace the traditional response criteria in ovarian cancer?显示文摘	Guppy AE Rustin GJ	2002	Oncologist2002，7，5：	1
13	Phase Ⅰ clinical trial of weekly combretastatin A4 phosphate:clinical and pharmacokinetic results显示文摘	Rustin GJ Galbraith SM Anderson H	2003	J Clin Oncol2003，21，15：	1
14	Role of tamour markers in monitoring epitheiouarian cancer 显示文摘	Meyer T Rustin GJ	2000	Br J Cancer2000，82，9：	1
15	Defining progression of ovari- an carcinoma during follow-up according to CA 125 :a north thames o- vary group study 显示文摘	Rustin GJ Nelstrop AE Tuxen MK	1996	Ann Oncol1996，7，2：	1
16	Vascular damaging agents 显示文摘	Patterson DM Rustin GJ	2007	Clin Oncol(R Coil Radiol)2007，19，：	1
17	Role of tumor markers in monitoring epithelial ovarian cancer 显示文摘	Meyer T Rustin GJ	2000	Br J Cancer2000，82，9：	1
18	Selection of active drugs for ovarian cancer based on CA125 and standard response rates in phase Ⅱ trails显示文摘	Rustin GJ Nelstrop AE Bentzen SM	2000	Clin Oncol2000，18，8：	1
19	Role of tumour markers in monitoring epithelial ovariancancer显示文摘	Meyer T Rustin GJ	2000	BrJCancer2000，82，9：	1
20	Use of CA-125 to de-fine progression of ovarian cancer in patients with persistently el-evated levels显示文摘	Rustin GJ Marples M Nelstrop AE	2001	J Clin Oncol2001，19，：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示